RNase H-independent antisense activity of oligonucleotide N3'->P5' phosphoramidates

被引:56
|
作者
Heidenreich, O
Gryaznov, S
Nerenberg, M
机构
[1] NANOGEN,SAN DIEGO,CA 92121
[2] HANNOVER MED SCH,D-30623 HANNOVER,GERMANY
[3] LYNX THERAPEUT,HAYWARD,CA 94545
[4] MED BIOL INST,LA JOLLA,CA 92037
关键词
D O I
10.1093/nar/25.4.776
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oligonucleotide N3'-->P5' phosphoramidates are a new and promising class of antisense agents. Here we report biological properties of phosphoramidate oligonucleotides targeted against the human T cell leukemia virus type-1 Tax protein, the major transcriptional transactivator of this human retrovirus. Isosequential phosphorothioate oligodeoxynucleotides and uniformly modified and chimeric phosphoramidate oligodeoxynucleotides containing six central phosphodiester linkages are all quite stable in cell nuclei, The uniformly modified anti-tax phosphoramidate oligodeoxynucleotide does not activate nuclear RNase H, as was shown by RNase protection assay, In contrast, the chimeric phosphoramidate-phosphodiester oligodeoxynucleotide is an efficient activator of RNase H, The presence of one or two mismatched nucleotides in the phosphodiester portion of oligonucleotides affected this activation only negligibly, When introduced into tax-transformed fibroblasts ex vivo, only the uniformly modified anti-tax phosphoramidate oligodeoxynucleotide caused a sequence-dependent reduction in the Tax protein level, Neither the chimeric phosphoramidate nor the phosphorothioate oligodeoxynucleotides significantly reduced tax expression under similar experimental conditions.
引用
收藏
页码:776 / 780
页数:5
相关论文
共 50 条
  • [1] Oligonucleotide N3'->P5' phosphoramidates as antisense agents
    Gryaznov, S
    Skorski, T
    Cucco, C
    NieborowskaSkorska, M
    Chiu, CY
    Lloyd, D
    Chen, JK
    Koziolkiewicz, M
    Calabretta, B
    NUCLEIC ACIDS RESEARCH, 1996, 24 (08) : 1508 - 1514
  • [2] OLIGONUCLEOTIDE N3'-]P5' PHOSPHORAMIDATES
    GRYAZNOV, SM
    LLOYD, DH
    CHEN, JK
    SCHULZ, RG
    DEDIONISIO, LA
    RATMEYER, L
    WILSON, WD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) : 5798 - 5802
  • [3] Synthesis and properties of the oligonucleotide N3'->P5' phosphoramidates
    Gryaznov, SM
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9): : 899 - 905
  • [4] Allosteric inhibitors of telomerase:: oligonucleotide N3′→P5′ phosphoramidates
    Pruzan, R
    Pongracz, K
    Gietzen, K
    Wallweber, G
    Gryaznov, S
    NUCLEIC ACIDS RESEARCH, 2002, 30 (02) : 559 - 568
  • [5] Oligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors
    Shea-Herbert, B
    Pongracz, K
    Shay, JW
    Gryaznov, SM
    ONCOGENE, 2002, 21 (04) : 638 - 642
  • [6] Oligonucleotide N3′ → P5′ phosphoramidates as potential therapeutic agents
    Gryaznov, SM
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01): : 131 - 140
  • [7] Oligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors
    Brittney Shea-Herbert
    Krisztina Pongracz
    Jerry W Shay
    Sergei M Gryaznov
    Oncogene, 2002, 21 : 638 - 642
  • [8] Erratum: Oligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors
    Brittney-Shea Herbert
    Krisztina Pongracz
    Jerry W Shay
    Sergei M Gryaznov
    Oncogene, 2002, 21 : 2774 - 2774
  • [9] SYNTHESIS OF OLIGODEOXYRIBONUCLEOTIDE N3'-]P5' PHOSPHORAMIDATES
    CHEN, JK
    SCHULTZ, RG
    LLOYD, DH
    GRYAZNOV, SM
    NUCLEIC ACIDS RESEARCH, 1995, 23 (14) : 2661 - 2668
  • [10] Oligonucleotide N3′ → P5′ Phosphoramidates and Thio-Phoshoramidates as Potential Therapeutic Agents
    Gryaznov, Sergei M.
    CHEMISTRY & BIODIVERSITY, 2010, 7 (03) : 477 - 493